Cargando…
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02
14-3-3 are regulatory proteins that through protein–protein interactions (PPI) with numerous binding partners could be involved in several human diseases, including cancer, neurodegenerative disorders, and pathogens infections. Following our research interest in the development of 14-3-3 PPI inhibit...
Autores principales: | Iralde-Lorente, Leire, Cau, Ylenia, Clementi, Letizia, Franci, Lorenzo, Tassone, Giusy, Valensin, Daniela, Mori, Mattia, Angelucci, Adriano, Chiariello, Mario, Botta, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853708/ https://www.ncbi.nlm.nih.gov/pubmed/30727786 http://dx.doi.org/10.1080/14756366.2019.1574779 |
Ejemplares similares
-
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
por: Tassone, Giusy, et al.
Publicado: (2021) -
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned So Far
por: Martellucci, Stefano, et al.
Publicado: (2020) -
Modulators of 14-3-3
Protein–Protein
Interactions
por: Stevers, Loes M., et al.
Publicado: (2017) -
Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures
por: Sabetta, Samantha, et al.
Publicado: (2023) -
Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models
por: Brai, Annalaura, et al.
Publicado: (2021)